Wei Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wei Wu has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Fangxun Bao
School of Mathematics, Shandong University, Jinan, China
1 shared publication Fang‐Pu Yu
The Key Laboratory of Cardiovascular Remodeling & Function Research, Chinese Ministry of Education, Chinese Ministry of Health & Chinese Academy of Medical Sciences, & The State & Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Qilu Hospital, Cheeloo College of Medicine Shandong University Jinan People's Republic of China
1 shared publication- Jinshuo Zhang
School of Mathematics, Shandong University, Jinan, Shandong, China
1 shared publication - Peibo Song1 shared publication
Pengfei Lin
Department of Neurology, Qilu Hospital of Shandong University, Jinan, Shandong, China
1 shared publication- Shujun Fu
Shandong University
1 shared publication
Latest Publications
- 8 March 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 46 (6) , 1516-1528
Serum metabolomics coupled with HR-VWI radiomics reveals metabolic alterations in asymptomatic carotid artery stenosis
Asymptomatic carotid artery stenosis (aCAS) increases the risk of ischemic stroke despite lacking clinical symptoms. This study sought to characterize the serum metabolic profile of aCAS and to identify potential biomarkers associated with plaque vulnerability by integrating metabolomics with radiomics. Untargeted metabolomic profiling was performed using liquid chromatography–tandem mass spectrometry (LC–MS/MS) on 72 participants, including 36 aCAS patients and 36 age- and sex-matched healthy controls (HC). Multivariate and univariate statistical analyses were conducted to screen differential metabolites. Candidate biomarkers were prioritized based on variable importance in projection (VIP) scores and random forest (RF) modeling. Plaque vulnerability features were quantified by high-resolution magnetic resonance vessel wall imaging (HR-VWI), and multi-omics analysis assessed associations between metabolites and plaque characteristics. A total of 144 significantly altered metabolites were identified between the aCAS and HC groups. Pathway enrichment analysis indicated that these differential metabolites were predominantly involved in lipid, purine, amino acid, nucleotide, and energy metabolism. Notably, 12R-HETrE, 9S-HOTrE, oleoylcarnitine, crichetocholic acid and 1β,3α,7α-trihydroxy-5β-cholan-24-oic acid—were significantly associated with radiomic markers of plaque vulnerability. This study delineates metabolic alterations in aCAS patients and identifies potential serum metabolic biomarkers associated with plaque vulnerability. Further validation is required.
- 8 March 2026
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 46 (6) , 1516-1528
Serum metabolomics coupled with HR-VWI radiomics reveals metabolic alterations in asymptomatic carotid artery stenosis
Asymptomatic carotid artery stenosis (aCAS) increases the risk of ischemic stroke despite lacking clinical symptoms. This study sought to characterize the serum metabolic profile of aCAS and to identify potential biomarkers associated with plaque vulnerability by integrating metabolomics with radiomics. Untargeted metabolomic profiling was performed using liquid chromatography–tandem mass spectrometry (LC–MS/MS) on 72 participants, including 36 aCAS patients and 36 age- and sex-matched healthy controls (HC). Multivariate and univariate statistical analyses were conducted to screen differential metabolites. Candidate biomarkers were prioritized based on variable importance in projection (VIP) scores and random forest (RF) modeling. Plaque vulnerability features were quantified by high-resolution magnetic resonance vessel wall imaging (HR-VWI), and multi-omics analysis assessed associations between metabolites and plaque characteristics. A total of 144 significantly altered metabolites were identified between the aCAS and HC groups. Pathway enrichment analysis indicated that these differential metabolites were predominantly involved in lipid, purine, amino acid, nucleotide, and energy metabolism. Notably, 12R-HETrE, 9S-HOTrE, oleoylcarnitine, crichetocholic acid and 1β,3α,7α-trihydroxy-5β-cholan-24-oic acid—were significantly associated with radiomic markers of plaque vulnerability. This study delineates metabolic alterations in aCAS patients and identifies potential serum metabolic biomarkers associated with plaque vulnerability. Further validation is required.
- 12 February 2026
- Published by Wiley in Annals of Neurology
- Vol. 99 (4) , 881-882
Ribbon‐Like Sign in Convexity Subarachnoid Hemorrhage
- 12 February 2026
- Published by Wiley in Annals of Neurology
- Vol. 99 (4) , 881-882
Ribbon‐Like Sign in Convexity Subarachnoid Hemorrhage
- 26 January 2026
- Published by Elsevier in Information Fusion
- Vol. 131
SU-RMT: Toward bridging semantic representation and structural detail modeling for medical image segmentation
- 26 January 2026
- Published by Elsevier in Information Fusion
- Vol. 131
SU-RMT: Toward bridging semantic representation and structural detail modeling for medical image segmentation